Literature DB >> 26698685

Characterizing clinical isolates of Acanthamoeba castellanii with high resistance to polyhexamethylene biguanide in Taiwan.

Fu-Chin Huang1, Min-Hsiu Shih1, Kai-Fei Chang2, Jian-Ming Huang2, Jyh-Wei Shin3, Wei-Chen Lin4.   

Abstract

BACKGROUND/
PURPOSE: Acanthamoeba keratitis (AK), a painful infectious corneal disease, is caused by the free-living pathogenic species Acanthamoeba. The symptoms include corneal infiltrate, epithelial, and stromal destruction, and loss of vision. Current treatment generally involves an hourly application of polyhexamethylene biguanide (PHMB) over a period of several days; however, even this is not entirely effective against all strains/isolates. The aims of this study were to confirm the existence of pathogenic strains in Taiwan which are highly resistant to drugs and to characterize the behavior of these strains.
METHODS: An in vitro Acanthamoeba species culture platform was established to observe the effectiveness of treatment and chart the morphological changes that occur under the effects of drugs using a light microscope and time-lapse recording. Changes in gene expression were examined using reverse transcription polymerase chain reaction (RT-PCR) and real-time PCR.
RESULTS: Over 90% of the standard strain cells (ATCC 30010) were lysed after being treated with PHMB for 1 hour; however, clinical isolates of Acanthamoeba castellanii that differed in their susceptibility to the treatment drug were only partly lysed. Following treatment with PHMB, National Cheng Kung University Hospital isolation B (NCKH_B) transformed into a pseudocyst under the effects of drug stress; however, National Cheng Kung University Hospital isolation D (NCKH_D), an isolate with higher tolerance for PHMB, did not transform.
CONCLUSION: Our results confirm the existence of clinical isolates of A. castellanii with high resistance to PHMB in Taiwan and present the alternative drug tolerance of A. castellanii in addition to the transformation of pseudocyst/cyst.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Acanthamoeba keratitis; drug tolerance; polyhexamethylene biguanide

Mesh:

Substances:

Year:  2015        PMID: 26698685     DOI: 10.1016/j.jmii.2015.10.011

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  12 in total

1.  Isolation and genotyping of Acanthamoeba strains (T4, T9, and T11) from amoebic keratitis patients in Iran.

Authors:  Elham Hajialilo; Massoud Behnia; Fatemeh Tarighi; Maryam Niyyati; Mostafa Rezaeian
Journal:  Parasitol Res       Date:  2016-04-22       Impact factor: 2.289

2.  Inhibitory effect of host ocular microenvironmental factors on chlorhexidine digluconate activity.

Authors:  Chun-Hsien Chen; Yu-Jen Wang; Jian-Ming Huang; Fu-Chin Huang; Wei-Chen Lin
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

3.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

4.  The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage.

Authors:  Fu-Chin Huang; Tao-Shen Liu; Sung-Chou Li; Min-Hsiu Shih; Jyh-Wei Shin; Wei-Chen Lin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-11-14       Impact factor: 4.077

5.  Extracellular vesicles and vesicle-free secretome of the protozoa Acanthamoeba castellanii under homeostasis and nutritional stress and their damaging potential to host cells.

Authors:  Diego de Souza Gonçalves; Marina da Silva Ferreira; Susie Coutinho Liedke; Kamilla Xavier Gomes; Gabriel Afonso de Oliveira; Pedro Ernesto Lopes Leão; Gabriele Vargas Cesar; Sergio H Seabra; Juliana Reis Cortines; Arturo Casadevall; Leonardo Nimrichter; Gilberto Barbosa Domont; Magno Rodrigues Junqueira; Jose Mauro Peralta; Allan J Guimaraes
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

6.  Validation of reference genes for the normalization of RT-qPCR gene expression in Acanthamoeba spp.

Authors:  Martina Köhsler; David Leitsch; Norbert Müller; Julia Walochnik
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

7.  Pathogenic Acanthamoeba castellanii Secretes the Extracellular Aminopeptidase M20/M25/M40 Family Protein to Target Cells for Phagocytosis by Disruption.

Authors:  Jian-Ming Huang; Chen-Chieh Liao; Chung-Ching Kuo; Lih-Ren Chen; Lynn L H Huang; Jyh-Wei Shin; Wei-Chen Lin
Journal:  Molecules       Date:  2017-12-18       Impact factor: 4.411

8.  High-Resolution Shear Wave Imaging of the Human Cornea Using a Dual-Element Transducer.

Authors:  Pei-Yu Chen; Cho-Chiang Shih; Wei-Chen Lin; Teng Ma; Qifa Zhou; K Kirk Shung; Chih-Chung Huang
Journal:  Sensors (Basel)       Date:  2018-12-03       Impact factor: 3.576

9.  Ursolic Acid Derivatives as Potential Agents Against Acanthamoeba Spp.

Authors:  Ines Sifaoui; Rubén L Rodríguez-Expósito; María Reyes-Batlle; Aitor Rizo-Liendo; José E Piñero; Isabel L Bazzocchi; Jacob Lorenzo-Morales; Ignacio A Jiménez
Journal:  Pathogens       Date:  2019-08-23

10.  Silver Nanoparticles as a Novel Potential Preventive Agent against Acanthamoeba Keratitis.

Authors:  Edyta B Hendiger; Marcin Padzik; Ines Sifaoui; María Reyes-Batlle; Atteneri López-Arencibia; Aitor Rizo-Liendo; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Olfa Chiboub; Rubén L Rodríguez-Expósito; Marta Grodzik; Anna Pietruczuk-Padzik; Karolina Stępień; Gabriela Olędzka; Lidia Chomicz; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathogens       Date:  2020-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.